Scalper1 News
Both Mylan (MYL) and Perrigo continued to climb on the stock market Thursday as Wall Street analyzed and speculated about a possible combination of the two. A day after Mylan’s unsolicited proposal, Leerink analyst Jason Gerberry wrote in a research note that Mylan could come out ahead whether it lands Perrigo (PRGO) or not. If it doesn’t, he said, Teva Pharmaceutical Industries (TEVA) will likely succeed in its widely rumored attempts to acquire Scalper1 News
Scalper1 News